Cargando…

Can Nordic alcohol and drug treatment benefit from a recovery perspective?

Detalles Bibliográficos
Autor principal:	Stenius, Kerstin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450861/ https://www.ncbi.nlm.nih.gov/pubmed/32934475 http://dx.doi.org/10.1177/1455072517696508

Ejemplares similares

Balancing welfare and market logics: Procurement regulations for social and health services in four Nordic welfare states
por: Stenius, Kerstin, et al.
Publicado: (2019)

Public health is not an innocent concept
por: Stenius, Kerstin
Publicado: (2018)

Sleep, recovery, and metaregulation: explaining the benefits of sleep
por: Vyazovskiy, Vladyslav V
Publicado: (2015)

Nordic alcohol statistics 2010–2015
por: Hellman, Matilda, et al.
Publicado: (2017)

The benefits of collaboration: the Nordic Arthroplasty Register Association
por: Mäkelä, Keijo T., et al.
Publicado: (2019)

Pancreatic cancer patients with germline BRCA mutations can benefit from olaparib treatment
por: Mukherjee, Shibani, et al.
Publicado: (2020)

The Nordic perspective on migration and empowerment
por: Dahl, Berit Misund, et al.
Publicado: (2020)

The Nordic health registers – an important source when evaluating the safety of antidepressants during pregnancy
por: Kieler, Helle
Publicado: (2010)

A New Tool to Assess the Epidemiology of Immune Thrombocytopenia: The Nordic Country Patient Registry for Romiplostim
por: Moulis, Guillaume
Publicado: (2019)

Preparing for the Nordic Skiing Events at the Beijing Olympics in 2022: Evidence-Based Recommendations and Unanswered Questions
por: Sandbakk, Øyvind, et al.
Publicado: (2021)

Depression and Antidepressants: A Nordic Perspective
por: Vilhelmsson, Andreas
Publicado: (2013)

Environmental Sustainability Perspectives of the Nordic Diet
por: Meltzer, Helle Margrete, et al.
Publicado: (2019)

Fetal Alcohol Spectrum Disorder: Can We Change the Future?
por: Popova, Svetlana, et al.
Publicado: (2020)

Climate-Smart Fiscal Policy Can Foster a Lasting Economic Recovery
por: Estevão, Marcello
Publicado: (2020)

Alcohol, drugs, tobacco and gambling form a lens for the Nordic welfare states’ biggest challenges
por: Hellman, Matilda
Publicado: (2023)

Globalization, Work, and Health: A Nordic Perspective
por: Torp, Steffen, et al.
Publicado: (2020)

Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective
por: Brolund, Alma
Publicado: (2014)

Why Research Should Pay Attention to Effects of Marketization of Addiction Treatment Systems
por: Storbjörk, Jessica, et al.
Publicado: (2019)

Drink Driving as the Commonest Drug Driving—A Perspective from Europe
por: Allsop, Richard
Publicado: (2020)

A comment on participant reimbursement within Australian drug and alcohol research
por: Winter, Daniel T., et al.
Publicado: (2022)

How Can We Best Use COVID-19 Vaccines in Adolescents? A Perspective From the United States
por: Tyungu, Donna L., et al.
Publicado: (2021)

Reviewing the Role of Instagram in Education: Can a Photo Sharing Application Deliver Benefits to Medical and Dental Anatomy Education?
por: Douglas, Naomi Katherine May, et al.
Publicado: (2019)

Alcohol consumption and alcohol policy in Estonia 2000–2017 in the context of Baltic and Nordic countries
por: Pärna, Kersti
Publicado: (2019)

Alcohol Dependence and Mortality: Implications for Treatment
por: Cook, Sarah
Publicado: (2015)

No time for business as usual: can systems thinking help us to accelerate recovery for early child development?
por: Milner, Kate M, et al.
Publicado: (2023)

Is it possible to recover from recovery?
por: Recke, Liese
Publicado: (2017)

Nitro-oleic acid as a new drug candidate for non-alcoholic steatohepatitis
por: Yang, Rui-Xu, et al.
Publicado: (2019)

Nonmedical Use of Prescription Drugs among Medical Students and the Relationship With Illicit Drug, Tobacco, and Alcohol Use
por: Papazisis, Georgios, et al.
Publicado: (2018)

Evolutionary concepts can benefit both fundamental research and applied research in toxicology (A comment on Brady et al. 2017)
por: Hahn, Mark E.
Publicado: (2018)

Collateral benefits: how the practical application of Good Participatory Practice can strengthen HIV research in sub‐Saharan Africa
por: Baron, Deborah, et al.
Publicado: (2018)

Assessing the Benefit-Risk for New Drugs: Are the FDA's Endocrinologic and Metabolic Drugs Advisory Committee and the Division of Metabolism and Endocrinology Products in sync?
por: Brass, Eric P.
Publicado: (2013)

Biomarkers That Predict an Unclear Benefit From Adjuvant Trastuzumab, Pertuzumab and Pembrolizumab When Those Same Drugs Were Given Neoadjuvantly
por: Sorscher, Steven
Publicado: (2022)

Commentary: When does the burden of treatment outweigh the biological benefit?
por: Blumenthaler, Alisa N., et al.
Publicado: (2020)

Generic drug policy in Australia: a community pharmacy perspective
por: Beecroft, Grahame
Publicado: (2007)

How can we realise the potentially large public health benefit of screening for type 2 diabetes mellitus in south Asians?
por: Stronks, K., et al.
Publicado: (2011)

Patient and public involvement in health research: A Nordic perspective
por: Sand, Anne-Sofie, et al.
Publicado: (2019)

Artificial intelligence in drug development: clinical pharmacologist perspective
por: Jang, In-Jin
Publicado: (2019)

Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?
por: Tanaka, Atsushi, et al.
Publicado: (2017)

A perspective from drug user organisations on ‘ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs’
por: Corbacho, Antonio, et al.
Publicado: (2014)

How Can We Best Use COVID-19 Vaccines in Adolescents? An International Perspective
por: Zhong, Youjia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ig8uoidps6olm5vr61rc97ueeb